INO - Inovio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-279,818
-279,818
-303,659
-166,411
-119,359
Depreciation & amortisation
5,496
5,496
4,731
4,628
5,516
Deferred income taxes
-
-
0
0
-260.818
Stock-based compensation
22,555
22,555
26,337
15,648
10,901
Change in working capital
19,834
19,834
50,351
-71,072
-3,543
Accounts receivable
-3,706
-3,706
11,032
-17,015
2,023
Accounts payable
32,607
32,607
26,141
3,251
-4,586
Other working capital
-217,185
-217,185
-216,940
-179,500
-98,838
Other non-cash items
186.977
186.977
858.644
2,364
5,231
Net cash provided by operating activities
-216,215
-216,215
-215,709
-177,979
-97,850
Cash flows from investing activities
Investments in property, plant and equipment
-969.153
-969.153
-1,231
-1,521
-987.926
Acquisitions, net
-2,000
-2,000
0
-1,400
-
Purchases of investments
-248,529
-248,529
-348,953
-156,217
-100,950
Sales/maturities of investments
361,084
361,084
174,840
62,991
92,893
Other investing activities
-
-
-
-2,775
-
Net cash used for investing activities
109,586
109,586
-175,344
-58,796
-9,045
Cash flows from financing activities
Common stock issued
82,955
82,955
209,441
454,486
9,089
Other financing activities
-1,398
-1,398
-4,611
-1,648
-1,135
Net cash used provided by (used for) financing activities
81,841
81,841
211,499
465,280
105,398
Net change in cash
-24,814
-24,814
-179,584
228,532
-1,498
Cash at beginning of period
71,144
71,144
250,728
22,196
23,694
Cash at end of period
46,329
46,329
71,144
250,728
22,196
Free cash flow
Operating cash flow
-216,215
-216,215
-215,709
-177,979
-97,850
Capital expenditure
-969.153
-969.153
-1,231
-1,521
-987.926
Free cash flow
-217,185
-217,185
-216,940
-179,500
-98,838